Change from conventional haemodiafiltration to on-line haemodiafiltration

Nephrology Dialysis Transplantation

Volumn 14, Issue 5, 1999, Pages 1202-1207

  Maduell, Francisco ^a   Del Pozo, Carlos ^b   Garcia, Hector ^b   Sanchez, Laura ^b   Hdez Jaras, Julio ^b   Albero, Maria D ^b   Calvo, Consuelo ^b   Torregrosa, Isidro ^b   Navarro, Victor ^b  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^b NONE

Author keywords

Adequate dialysis; Convection; Conventional haemodiafiltration; On line haemodiafiltration

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BETA 2 MICROGLOBULIN; BICARBONATE; CALCIUM; CHOLESTEROL; ERYTHROPOIETIN; HEMOGLOBIN; INFUSION FLUID; PARATHYROID HORMONE; PHOSPHATE; POTASSIUM; PROTEIN; PYROGEN; SODIUM; TRIACYLGLYCEROL; UREA; UREMIC TOXIN; URIC ACID;

ADULT; AGED; ANEMIA; ARTICLE; ARTIFICIAL MEMBRANE; BIOCHEMISTRY; BLOOD FILTRATION; BLOOD FLOW; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIALYSATE; DIFFUSION; FEMALE; FLOW; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; KINETICS; MALE; MEDICAL TECHNOLOGY; MOLECULAR SIZE; MULTICENTER STUDY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN DEGRADATION; TECHNIQUE; THERMODYNAMICS; TIME;

ADULT; AGED; BETA 2-MICROGLOBULIN; ERYTHROPOIETIN, RECOMBINANT; EVALUATION STUDIES; FEMALE; HEMATOCRIT; HEMODIAFILTRATION; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; UREA;

EID: 0032950557     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.5.1202     Document Type: Article

References (32)

1. Wizemann V, Kramer W, Knopp G, Rawer P, Mueller K, Schütterle G. Ultrashort hemodiafiltration: efficiency and hemodynamic tolerance. Clin Nephrol 1983; 19: 24-30
2. Ronco C. Hemofiltration and hemodiafiltration. In Bosch JP and Stein JH, ed. Hemodialysis: High-efficiency Treatments. Churchill Livingstone, New York, 1993; pp. 119-133
3. Baldamus CA, Pollok M. Ultrafiltration and hemofiltration: practical applications. Maher E, ed. Replacement of Renal Function by Dialysis. 3rd edn. Kluwer, Boston, 1989; pp. 327-339
4. Mion M, Kerr PG, Argiles A, Canaud B, Flavier JL, Mion CM. Hemodiafiltration in high-cardiovascular-risk patients. Nephrol Dial Transplant 1992; 7: 453-455
5. Bigazzi R, Paparatto P, Setti GP, Raugi M, Baldari G. Biofiltration, a new method of short hemodiafiltration: preliminary report. Int J Artif Org 1986; 9 [Suppl 3]: 111-114
6. Cappelli G, Icardi A, Lamperi D, Lamperi S. Effects of biofiltration versus hemofiltration in the treatment of chronic uremia. Int J Artif Org 1986; 9 [Suppl 3]: 21-24
7. Von Albertini B, Miller J, Garner P, Shinaberger J. High flux hemodiafiltration: under six/hour/week treatment. Trans Am Soc Artif Intern Org 1984; 30: 227-231
8. Ghezzi PM, Frigato G, Fantini GF et al. Theoretical model and first clinical results of the paired filtration dialysis (PFD). Life Support Systems 1983; 1 [Suppl 1]: S271-S275
9. Santoro A, Ferrari G, Spongano M, Badiali F, Zuchelli P. Acetate free biofiltration: a viable alternative to bicarbonate dialysis. Int J Artif Org 1989; 13: 476-479
10. Canaud B, Flavier JL, Argiles A, et al. Hemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy. Contrib Nephrol 1994; 108: 12-22
11. Shaldon S, Beau MC, Deschodt G, Mion C. Mixed hemodiafiltration (MHF): 18 months experience with ultrashort treatment time. Trans Am Soc Artif Intern Org 1981; 27: 610-612
12. Shinzato T, Sezaki R, Usuda M, Maeda K, Ohbayashi S, Toyoto T. Infusion-free hemodiafiltration: simultaneous hemofiltration and dialysis with no need for infusion fluid. Artif Org 1982; 6: 453
13. Miller JH, von Albertini B, Gardner PW, Shinaberger JH. Technical aspects of high-flux hemodiafiltration for adequate short (under 2 hours) treatment. Trans Am Soc Artif Intern Org 1984; 30: 377-380
14. Canaud B, Kerr P, Argiles A, Flavier JL, Stec F, Mion C. Is hemodiafiltration the dialysis modality of choice for the next decade? Kidney Int 1993; 43 [Suppl 41]: S296-S299
15. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Nephrol 1993; 4: 1205-1213
16. Maduell F, Garcia-Valdecasas J, Garcia H et al. Urea reduction ratio considering urea rebound. Nephron 1998; 78: 143-147.
17. Maduell F, Garcia-Valdecasas J, Garcia H et al. Validation of different methods to calculate Kt/V considering postdialysis rebound. Nephrol Dial Transplant 1997; 12: 1928-1933.
18. 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991; 39: 909-919
19. 2-microglobulin in hemodialysed patients. Nephron 1978; 21: 260-269
20. 2-microglobulin in hemodialysis. Contrib Nephrol 1991; 74: 132-139
21. Chandna SM, Tattersall JE, Nevett G et al. Low serum vitamin B12 levels in chronic high-flux haemodialysis patients. Nephron 1997; 75: 259-263
22. Ahrenholz P, Winkler E, Ramlow W, Tiess M, Müller W. Online hemodiafiltration with pre- and postdilution: a comparison of efficacy. Int J Artif Org 1997; 20: 81-90
23. Held PJ, Port FK, Wolfe RA et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50: 550-556
24. NKF-DQQI Hemodialysis Adequacy Work Group Membership. Measurement of hemodialysis adequacy. Am J Kidney Dis 1997; 30 [Suppl 2]: S22-S31
25. Eknoyan G, Levey AS, Beck GJ et al. Hemodialysis (HEMO) study: rationale for selection of interventions. Semin Dial 1996; 9: 24-33
26. Daugirdas JT, Depner TA, Gotch FA et al. Comparison of methods to predict equilibrated Kt/V in the HEMO pilot study. Kidney Int 1997; 52: 1395-1405
27. Bonforte G, Beretta M, Baj A et al. Anemia and hemodiafiltration with on-line production of infusion fluid. Nephrol Dial Transplant 1997; 12: A168
28. Paganini EP, Abdulhadi MH, Garcia J, Magnusson MO. Recombinant human erythropoietin correction of anemia in hemodialyzed patients: Dialysis efficiency, waste retention, and chronic dose variables. Trans Am Soc Artif Intern Org 1989; 35: 513-515
29. Charra B, Calemard E, Ruffet M et al. Supervival as an index of adequacy in dialysis. Kidney Int 1992; 41: 1286-1291
30. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996; 334: 420-425
31. Eschbach JW. EPO treatment in dialysis. Which hematocrit target? Does dialysis quality influence dose? International Congress of Nephrology, Madrid. 1995; p. 90 (Abstract)
32. Ono M, Taoka M, Takagi T, Ogawa H, Saito A. Comparison of types of on-line hemodiafiltration from the standpoint of low-molecular-weight protein removal. Contrib Nephrol 1994; 108: 38-45